|
| Exchange Received Time 22/10/2018 08:51:48 Exchange Disseminated Time 22/10/2018 08:51:53 Time Taken 00:00:05 | With reference to the captioned subject, this is to inform the exchange that Aleor Dermaceuticals Ltd. (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals Ltd. (Alembic) and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular), has successfully cleared its first United States Food and Drugs Administration (USFDA) inspection of its new formulation manufacturing facility located at Karakhadi, Gujarat, India; without any observations.
Please find enclosed herewith our press release.
We request you to kindly take the same on record.
|
|
|